| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3860 |
| Trial ID | NCT06378190 |
| Disease | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TranspoCART19 cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Multicentre Phase I/IIa Study of Infusion of Autologous Peripheral Blood T Lymphocytes Expanded and Genetically Modified Using Sleeping Beauty Family Transposons to Express a Chimeric Antigenic Receptor With Anti-CD19 Specificity Conjugated to the 4-1BB Co-stimulatory Region and CD3z and huEGFRt Signal Transmission (TranspoCART19) in Patients With Relapsed or Refractory B-cell Lymphoma |
| Year | 2024 |
| Country | Spain |
| Company sponsor | Instituto de Investigación Biomédica de Salamanca |
| Other ID(s) | TranspoCART19|2022-001040-23 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||